alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › therapy-development

therapy-development

2 studies tagged therapy-development, dated 2022-01-04 to 2024-06-27. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development 2024-06-27
  2. Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders 2022-01-04

Studies

2 studies carry this tag.

Date range

2022 to 2024

Top journals

  • CNS drugs 1
  • Neurological research and practice 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. CNS drugs 2024-06-27 Treatments

    Alzheimer's disease (AD) is a complex multifaceted disease.

  2. Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurological research and practice 2022-01-04 Drug development

    RNA-based therapies offer chances for therapy development of complex neurodegenerative disorders such as amyotrophic lateral sclerosis, muscular dystrophies, Parkinson's and Alzheimer's disease.

All topic tags with their study counts